ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,532.30
0.45%
S&P ASX All Technology
3,983.90
1.06%
Brent Oil
76.385
0.00%
US Dollar vs AUD
1.60334
0.00%
Bitcoin
102,294.10
-0.12%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Finch Therapeutics Group Inc (PK) (FNCH) Share Price

Finch Therapeutics Group Inc (PK)

Finch Therapeutics Group Inc (PK) (FNCH)

USOTC
11.2518
0.1018
(0.91%)
Closed 01 February 8:00AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
11.2518
Bid
10.90
Offer
11.75
Volume
2,167
11.16 Day's Range 11.2518
0.80 52 Week Range 14.26
Market Cap
18.068M
Previous Close
11.15
Open
11.16
Last Trade
400
@
11.2518
Last Trade Time
Financial Volume
US$ 24,194
VWAP
11.1649
Average Volume (3m)
2,350
Shares Outstanding
1,605,763
Dividend Yield
-
PE Ratio
-0.24
Earnings Per Share (EPS)
-46.55
Revenue
107k
Net Profit
-74.75M

About Finch Therapeutics Group Inc (PK)

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.finchtherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Finch Therapeutics Group Inc (PK) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker FNCH. The last closing price for Finch Therapeutics (PK) was US$11.15. Over the last year, Finch Therapeutics (PK) shares have traded in a share price range of US$ 0.80 to US$ 14.26.

Finch Therapeutics (PK) currently has 1,605,763 shares in issue. The market capitalisation of Finch Therapeutics (PK) is US$17.90 million. Finch Therapeutics (PK) has a price to earnings ratio (PE ratio) of -0.24.

Ask ADVFN Intelligence (AI)

FNCH Latest News

More News

Form EFFECT - Notice of Effectiveness

05 November 2024
Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement

01 November 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

01 November 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

01 November 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

01 November 2024
Edgar (US Regulatory)

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities

31 October 2024
Edgar (US Regulatory)

Form 8-K - Current report

21 October 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 August 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.25182.289090909091111.562511143311.26514306CS
4-0.2482-2.1582608695711.511.562510.9111311.0890622CS
12-0.2982-2.5818181818211.5512.1510.15235011.37804842CS
269.3718498.51.8814.261.4181078.9855063CS
5210.0518837.651.214.260.885516.62906267CS
15610.0518837.651.214.260.885516.62906267CS
26010.0518837.651.214.260.885516.62906267CS

FNCH - Frequently Asked Questions (FAQ)

What is the current Finch Therapeutics (PK) share price?
The current share price of Finch Therapeutics (PK) is US$ 11.2518
How many Finch Therapeutics (PK) shares are in issue?
Finch Therapeutics (PK) has 1,605,763 shares in issue
What is the market cap of Finch Therapeutics (PK)?
The market capitalisation of Finch Therapeutics (PK) is USD 17.9M
What is the 1 year trading range for Finch Therapeutics (PK) share price?
Finch Therapeutics (PK) has traded in the range of US$ 0.80 to US$ 14.26 during the past year
What is the PE ratio of Finch Therapeutics (PK)?
The price to earnings ratio of Finch Therapeutics (PK) is -0.24
What is the cash to sales ratio of Finch Therapeutics (PK)?
The cash to sales ratio of Finch Therapeutics (PK) is 168.92
What is the reporting currency for Finch Therapeutics (PK)?
Finch Therapeutics (PK) reports financial results in USD
What is the latest annual turnover for Finch Therapeutics (PK)?
The latest annual turnover of Finch Therapeutics (PK) is USD 107k
What is the latest annual profit for Finch Therapeutics (PK)?
The latest annual profit of Finch Therapeutics (PK) is USD -74.75M
What is the registered address of Finch Therapeutics (PK)?
The registered address for Finch Therapeutics (PK) is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Finch Therapeutics (PK) website address?
The website address for Finch Therapeutics (PK) is www.finchtherapeutics.com
Which industry sector does Finch Therapeutics (PK) operate in?
Finch Therapeutics (PK) operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXGBNxGen Brands Inc (CE)
US$ 0.003
(299,900.00%)
180.55k
DOCKFBeyond Med Technologies Inc (PK)
US$ 0.055
(54,900.00%)
3.05k
SDCCQSmileDirectClub Inc (CE)
US$ 0.0004
(39,900.00%)
52.05k
LTFDLittlefield Corporation (CE)
US$ 0.1525
(38,025.00%)
240
SGMDSugarmade Inc (CE)
US$ 0.0003
(29,900.00%)
5.94k
RTNBroot9B Holdings Inc (CE)
US$ 0.000001
(-99.97%)
666
THMOThermoGenesis Holdings Inc (CE)
US$ 0.000001
(-99.86%)
250
DOMWFPrime Drink Group Corporation (PK)
US$ 0.0012
(-99.08%)
311.03k
TTCMTautachrome Inc (CE)
US$ 0.000001
(-99.00%)
125.07k
MITJFMint Corporation (CE)
US$ 0.0001
(-99.00%)
12k
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
316.07M
HMBLHUMBL Inc (PK)
US$ 0.0007
(0.00%)
218.85M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(-25.00%)
210.68M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(0.00%)
171.31M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00275
(-1.79%)
134.31M

Discussion

View Full Feed
Stock_Barber Stock_Barber 5 minutes ago
Excellent find!

Fuse lit!

Stickied!

👍️
JNSH
3331 3331 7 minutes ago
ACTIPATCH and RECOVERYRX ARE MORE EFFECTIVE (PAIN REDUCTION AND COST) than JOURNAVX!

BIEL competitor VRTX just received FDA approval for JOURNAVX despite it showing essentially no effectiveness in a Phase 2 study for LSR - JOURNAVX showed a mean reduction of 2.02 points on the NPRS at
VRTX
rogers711 rogers711 8 minutes ago
I think it's downhill until news in my opinion..
RDGL
Tbags7 Tbags7 8 minutes ago
Got the election resulted they needed so that was a big first step in the right direction.  
GSPE
BDEZ BDEZ 9 minutes ago
More than ten thousand Qurans were burned in the last 24 hours in protest of the killing of Salwan Momika and in support of his ideas

https://x.com/mountlevnon/status/1885401190063566858
DonVance DonVance 9 minutes ago
Of course it's relevant. These assets are all highly correlated.
CBDS
janice shell janice shell 11 minutes ago
She attended Central Catholic High School in Lawrence, Massachusetts. She then attended Saint Anselm College[9][1] on a scholarship for NCAA Division II college softball.[10] Leavitt was outspoken on campus about her support for the Trump administration.

And her husband is a real esta
BDEZ BDEZ 12 minutes ago
Canada is prepared to offer pandemic-level financial support to workers and businesses if the US imposes tariffs.

Officials emphasize that workers should not bear the costs of US decisions, referencing past Covid-19 responses as a model for potential aid, per CBC
norisknorewards norisknorewards 12 minutes ago
Why does anyone (obviously) short show up after an (obviously) positive development for longs turn up?

It's weird, all these rich guys, you'd think they would be out at dinner, not terrified of an update on pacer late on a friday
NWBO
BDEZ BDEZ 12 minutes ago
Commie Jeffries calls for violence as he says people must "fight" President Trump's agenda "in the streets."
3331 3331 13 minutes ago
BIEL +50% GOLDEN CROSS BREAKOUT, 911 NEWS PENDING!
BDEZ BDEZ 13 minutes ago
Zuckerberg's $META in talks to exit Delaware and reincorporate in Texas, per WSJ
META
BDEZ BDEZ 13 minutes ago
Zuckerberg's $META in talks to exit Delaware and reincorporate in Texas, per WSJ
META
norisknorewards norisknorewards 13 minutes ago
Lol thanks for the additional transparency
NWBO
pos_stock_hoarder pos_stock_hoarder 13 minutes ago
That's really terrible. I wonder what the heck happened here?!
Roman516 Roman516 14 minutes ago
NoGro, and false information,

Per your comment,
"It's why there are so many negative comments and contrary publications challenging the conclusions of the trial."
This is bogus information as the ratio of negative comments to positive comments is approximately 2:25.
NWBO
CorsairNavigator20 CorsairNavigator20 14 minutes ago
He is a successful business person, woke up (pun intended) and said, do I really want to be ignored. He walked away and will come back to buy us for ten cents on the dollar. The good news, there's none for us.
MRKR
3331 3331 14 minutes ago
BIEL: BUYOUT/MERGER?
Sree Koneru, PhD's appointment to the Board of Directors at BioElectronics Corporation is a strategic move that will likely contribute to the company's growth and innovation in the medical technology sector.

Dr. Koneru is currently Director of Program Manag
BDEZ BDEZ 15 minutes ago
Canada is prepared to offer pandemic-level financial support to workers and businesses if the US imposes tariffs.

Officials emphasize that workers should not bear the costs of US decisions, referencing past Covid-19 responses as a model for potential aid, per CBC
3331 3331 16 minutes ago
BIEL: BUYOUT/MERGER?
Sree Koneru, PhD's appointment to the Board of Directors at BioElectronics Corporation is a strategic move that will likely contribute to the company's growth and innovation in the medical technology sector.

Dr. Koneru is currently Director of Program Manag

Your Recent History

USOTC
FNCH
Finch Therapeutics (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads